COVID-19 laboratory preparedness and response in the Americas Region: Lessons learned.

COVID-19 laboratory preparedness and response in the Americas Region: Lessons learned.
复制标题

美洲地区的 COVID-19 实验室准备和应对:经验教训。

DOI:
10.1371/journal.pone.0253334
复制
发表时间:
2021
期刊:
影响因子:
3.7
通讯作者:
Mendez-Rico J
Mendez-Rico J
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Leite JA;Gresh L;Vicari A;Gabastou JM;Perez E;Aldighieri S;SARINET laboratories Network;Mendez-Rico J

文献摘要

参考文献

被引文献

相似文献

当COVID-19的病原体被确定为一种新型冠状病毒时,美洲地区还没有一个国家拥有检测这种新病毒的实验室能力。为使国家参考实验室及时做好检测SARS-CoV-2的准备,制定了多层次战略办法,包括购买和交付具体试剂、区域培训、国内访问和提供技术支持。所有国家都应做好准备,及时发现任何潜在的大流行新病原体。在整个美洲实施的SARS-CoV-2快速分子检测表明,有效和协调一致的实验室应对措施对防范工作至关重要。在这里,我们介绍了美洲地区如何在25天内从没有SARS-CoV-2诊断能力,到在泛美卫生组织的协调战略下,在区域和国家一级与国家当局和公共卫生实验室的合作下,在28个成员国全面实施分子检测。
By the time the etiologic agent of the COVID-19 was identified as a novel coronavirus, no country in the Americas Region had laboratory capacity for detecting this new virus. A strategic multilevel approach with specific reagent purchase and delivery, regional trainings, in-country missions, and the provision of technical support was established for timely preparedness of national reference laboratories for SARS-CoV-2 detection. All countries should be prepared to timely detect any potential pandemic emerging agent. The rapid SARS-CoV-2 molecular detection implementation throughout the Americas showed the importance of an efficient and coordinated laboratory response for preparedness. Here we present how in 25 days the Americas Region went from no SARS-CoV-2 diagnostic capacity, to molecular detection fully implemented in 28 Member States, under the coordinated strategy of the Pan American Health Organization and collaborative work at regional and country level with national authorities and public health laboratories.
DOI: 10.2807/1560-7917.es.2020.25.3.2000045
发表时间: 2020-01-23
期刊: EUROSURVEILLANCE
影响因子: 19
作者:
Corman, Victor M.;Landt, Olfert;Drosten, Christian
通讯作者: Drosten, Christian